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Hox proteins gain specificity by interacting with TALE-class cofactors. In a recent issue of Cell and in this
issue of Developmental Cell, Crocker et al. (2015) and Amin et al. (2015), respectively, demonstrate that
non-canonical Hox/TALE binding sequences play a major role in the regionalized regulation of target gene
expression in vivo.Hox proteins are conserved homeodo-
main (HD)-containing transcription fac-
tors (TFs) that regulate distinct sets of
target genes to coordinate a large num-
ber of diverse cell fates during embryo-
genesis (Hueber and Lohmann, 2008).
They all bind with high affinity to nearly
identical sequences in vitro (Noyes
et al., 2008). The lack of DNA-binding
specificity in vitro stands in sharp
contrast to the highly specific functions
executed by Hox proteins in vivo. This
so-called ‘‘Hox paradox’’ was partially
resolved by the identification of the PBC
and Meis cofactors (Mann et al., 2009),
which assist Hox proteins in controlling
several developmental processes. PBC
and Meis proteins belong to the TALE
family of HD-containing TFs, and their
presence dramatically changes the
DNA-binding properties of Hox proteins
in vitro. More specifically, the interaction
with PBC TFs was shown to allow Hox
proteins to preferentially recognize
different heterodimeric binding sites,
thereby revealing a ‘‘latent specificity’’
(Slattery et al., 2011). These heterodi-
meric binding sites differ at the level of
the two central nucleotide positions
(Figure 1A), which are important for
dictating specific shapes of the DNA mi-
nor groove. Structural analyses provided
molecular insights into the role of pa-
ralog-specific residues located within
and outside of the HD for recognizing
these specific shapes (Joshi et al.,
2007). Together, these studies illustrate
the in-depth knowledge gained so far
regarding the molecular mechanisms un-
derlying Hox/TALE binding on consensus
sequences in vitro.In a recent issue of Cell, Crocker and
colleagues (2015) now show that a
Drosophila Hox/TALE complex regulates
a specific target gene by recognizing
clusters of low-affinity binding sites that
are strongly divergent from the consensus
motif. The authors demonstrate that these
atypical binding sites are important for
specificity and robustness of the Hox
target enhancer in vivo. Similarly, Amin
and colleagues (2015) describe that
Hoxa2 assists the TALE class protein
Meis2 to interact with partial consensus
sites for target gene regulation in the
second branchial arch of the mouse
embryo.
Using the regulation of the trichome
selector gene shaven baby (svb) by the
Drosophila Hox protein Ultrabithorax
(Ubx) as a model, Crocker and colleagues
(2015) found that none of the previously
described consensus Hox/TALE binding
sequences were present in the enhan-
cers recapitulating svb expression in the
abdomen. In contrast, the regulation of
svb by Ubx/TALE complexes was shown
to completely rely on homotypic clusters
of divergent and low Hox affinity binding
sites (Figure 1B). Importantly, by progres-
sively changing these native sites into
high-affinity consensus sequences, other
Hox/TALE complexes gained the ability
to interact with the enhancers in vitro,
and, as a consequence, enhancer activity
was now also put under the control of
these additional Hox/TALE complexes
in vivo. These results unambiguously de-
monstrate that native low-affinity binding
sites confer specificity to Hox proteins
and raise the question as to which role
the redundant Hox binding sites mightDevelopmental Cell 32play in orchestrating target gene regula-
tion. Interestingly, the authors reveal that
clusters of low-affinity binding sites confer
a more robust enhancer activity under
various environmental stress conditions.
This ‘‘shadow-like’’ regulatory mecha-
nism (Perry et al., 2010) is evolutionary
conserved, as several low-affinity binding
sites for Ubx/TALE complexes are also
found in orthologous enhancers of svb in
Drosophila virilis.
Partial consensus binding sites in-
volved in Hox target gene regulation are
also the focus of thework of Amin and col-
leagues (2015), who describe in this issue
of Developmental Cell how Hoxa2 in-
structs second branchial arch (IIBA) mor-
phologies in the mouse embryo by modi-
fying a branchial arch ground state ruled
by Meis. Hoxa2 does not accomplish
this function by changing the DNA-bind-
ing specificities of Meis, but rather by
enhancing its binding affinity to a subset
of sites. These sites are often found close
to various Hoxa2 and Hoxa2/PBC binding
sites and located within enhancers of
Hoxa2 target genes that are strongly ex-
pressed in the IIBA. Surprisingly, the syn-
ergistic binding sequences of Meis2 with
Hoxa2 are preferentially enriched in par-
tial Meis consensus recognition motifs
(Figure 1C). Thus, the presence of Hoxa2
in the IIBA does not change qualitatively,
but does quantitatively change Meis
DNA binding on potentially lower-affinity
sites across the genome to switch its
transcriptional program.
Together, the work of Crocker et al.
(2015) and Amin et al. (2015) uncover
a mechanism underlying fundamental de-
velopmental programs in vertebrates and, February 9, 2015 ª2015 Elsevier Inc. 259
Figure 1. Consensus and Non-Consensus Nucleotide Sequences in Hox/TALE DNA-Binding
Specificity
(A) Three different types of consensus binding sites are preferentially recognized by Hox/TALE complexes
in vitro. Crystal structures showed a predominant role of the hexapeptide (HX) motif for complex formation
on the consensus sequences. (B) Nucleotide sequences of atypical binding sites recognized by Ubx/TALE
or AbdA/TALE complexes on characterized native enhancers inDrosophila. The UbdA (UA) motif is known
to be important for association with TALE cofactors on the Distalless repressor element (DllR) (Merabet,
and Hudry, 2013). Motif(s) required for the interaction with TALE cofactors on the other enhancers are
not known (questionmarks). Note that AbdA could also formDNA-binding complexeswith TALE cofactors
on E3N and DllR. The topology of Meis binding sites is speculative on E,3N. (C) Nucleotide sequences
(Hox-PBC and/or Hox together with Meis) of most frequent sites found in regions of synergistic binding
of Meis, and Hoxa2, in the IIBA. The dotted arrows show possible interaction. Note that the consensus
binding site for PBC is also not complete. High- and low-affinity binding sites are highlighted by large
or thin boxes, respectively.
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Previewsinvertebrates: the role of non-canonical
binding sequences in Hox/TALE respon-
sive enhancers. But if binding specificity
is all about atypical sites, how could this
have been missed for so long?
Hints for a role for atypical sites in Hox
target enhancers can be found earlier.
For example, the Drosophila Labial (Lab)260 Developmental Cell 32, February 9, 2015protein was shown to recognize an atyp-
ical Lab/TALE binding site for the regula-
tion of a specific target gene in the en-
doderm (Ebner et al., 2005). Along the
same lines, it was noticed previously
that several characterized native target
enhancers of Hox/TALE complexes do
not contain consensus binding se-ª2015 Elsevier Inc.quences, as exemplified for Drosophila
Ubx and AbdominalA (AbdA) proteins
(Figure 1B; see also Mann et al., 2009).
Thus, Hox/TALE-specific functions might
rely on an unexpected and so far underes-
timated number of non-consensus bind-
ing sites in vivo. In this context, we might
need to reconsider the stringent criteria
generally used in computational analy-
ses and predictions of genome-wide
binding data for identifying cis-regulatory
sequences.
Finally, the molecular mechanisms al-
lowing different Hox/TALE complexes to
recognize these potentially highly diverse
binding sites remain to be unraveled.
Structures of Hox/PBC complexes were
thus far solved only on high-affinity bind-
ing sites (Mann et al., 2009). All of them
converge to support the predominant
role of a unique motif of Hox proteins,
called hexapeptide (HX), in making
strong interactions with the PBC partner
(Figure 1A). However, these results are
in contradiction with the observation
that this conserved motif is dispensable
in several Hox proteins for interaction
and function with TALE cofactors in vivo
(Merabet and Hudry, 2013). It is tempting
to postulate that the distinct regulatory
activities of Hox/TALE complexes rely
on their interaction via different protein
motifs. This differential interaction mode
could be dictated by the nature of the
DNA-binding site, in particular its affi-
nity level for the Hox/TALE complex
(Figure 1B). In this context, the role of
other unknown cofactors has to be
considered. In any case, solving addi-
tional Hox/TALE structures on native
and low-affinity binding sites constitutes
a mandatory challenge in order to better
understand the Hox paradox in the
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Navarro-Le´rida et al. (2015) report in this issue ofDevelopmental Cell that RAC1 nuclear accumulation causes
actin-dependent deformation of the nuclear envelope and increases nuclear plasticity. It further leads to
depletion of cytoplasmic, active RAC1 with a concomitant increase in RHOA signaling driving actomyosin-
mediated cell shape changes. These two properties combine to enhance tumor cells invasiveness.RAC1,amemberof theRHOfamilyof small
GTPases, controls a wide array of cellular
functions, including actin remodeling for
cell ruffling, adherens junction formation,
cell motility, and polarity. RAC1 has also
been implicated in cellular transformation
andcancerprogressionvia its role incell in-
vasion (Bosco et al., 2009). A key function
ofRAC1 is the control of ARP2/3-mediated
branched actin polymerization, which is
required for the formation of membrane
protrusions that drive mesenchymal mo-
tility in virtually all cells, including cancer
cells (Bisi et al., 2013). Notably, metastatic
cancer cells negotiate the diverse micro-
environmental conditions they encounter
by adopting flexible invasive strategies
(Wolf and Friedl, 2011). In ‘‘mesenchymal
motility,’’ invasion is achieved by coupling
polarized actin-based protrusions with
spatially restricted pericellular proteolytic
activity in bothmigrating cells and reactive
stromal cells (Wolf and Friedl, 2011). In
‘‘amoeboid motility,’’ by contrast, cancer
cells use actomyosin-based mechanical
forces to displace matrix fibrils while
adopting a rounded cell shape. Whereas
mesenchymal motility depends on RAC1,
amoeboid migration involves RHOA
(Sanz-Moreno et al., 2011). Thus, a tight
interplay between these GTPases dictatesindividual tumor cells’ invasion strategy.
Furthermore, these cells must constantly
deform and plastically adapt their nuclei
to squeeze throughnarrowgapsof intersti-
tial tissues (Wolf and Friedl, 2011). In this
issue of Developmental Cell, Navarro-Le´r-
ida et al. (2015) show that nucleocyto-
plasmic shuttling of RAC1 impacts both
cell shape—by regulating the balance of
cytoplasmic RAC1/RHOA activities—and
nuclear plasticity and deformability, thus
contributing to the regulation of cell
invasion.
Numerous guanine nucleotide ex-
change factors (GEFs) and GTPase acti-
vating proteins (GAPs), combined with a
variety of downstream effectors, enable
RAC1 to produce a diverse array of
signaling outputs (Bosco et al., 2009).
However, the differential regulation of
signaling by RAC1 in different contexts re-
mains poorly understood. Furthermore,
increasing evidence suggests that sub-
cellular compartmentalization plays a ma-
jor role in regulating the signaling output
of RAC1. In addition to the cytosol and
plasma membrane, RAC1 also localizes
to endosomes (Palamidessi et al., 2008)
and the nucleus (Kraynov et al., 2000).
RAC1 activation on early endosomes
and subsequent recycling of RAC1 tothe plasma membrane ensure polarized
signaling, leading to localized actin-based
migratory protrusions (Palamidessi et al.,
2008) and spatial restriction of RAC1
motogenic signals, which promotes me-
senchymal motility. In the nucleus, accu-
mulation of RAC1 has been linked to regu-
lation of RAC1 proteosomal degradation
(Lanning et al., 2004). Additionally, cell-
cycle-dependent accumulation of nuclear
RAC1 promotes mitotic progression (Mi-
chaelson et al., 2008). These findings sug-
gest that nucleocytoplasmic shuttling is
important for the spatial control of specific
RAC1 functions.
An elegant study by the Del Pozo group
now examines the processes that con-
tribute to, and are impacted by, RAC1 nu-
cleocytoplasmic shuttling (Navarro-Le´r-
ida et al., 2015). The authors, through a
proteomic approach, initially identified
nucleophosmin (nucleolar phosphopro-
tein B23) as a nuclear binding partner of
RAC1. B23 is a multifunctional phospho-
protein involved in ribosome biogenesis.
It shuttles between the nucleus and the
cytoplasm, interacting with a variety of
proteins and acting as a bona fide chap-
erone (Colombo et al., 2011). Indeed, the
authors show that RAC1 utilizes B23 for
nucleocytoplasmic shuttling and that the, February 9, 2015 ª2015 Elsevier Inc. 261
